Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approaches.
2017-12-08 07:46来源：原版作者：Krebs MG
Epithelial circulating tumor cells (CTCs) are detectable in patients with non-small cell lung cancer (NSCLC). However, epithelial to mesenchymal transition, a widely reported prerequisite for metastasis, may lead to an underestimation of CTC number. We compared directly an epithelial marker-dependent (CellSearch) and a marker-independent (isolation by size of epithelial tumor cells [ISET]) technology platform for the ability to identify CTCs. Molecular characteristics of CTCs were also explored.
Paired peripheral blood samples were collected from 40 chemon?ive, stages IIIA to IV NSCLC patients. CTCs were enumerated by Epithelial Cell Adhesion Molecule-based immunomagnetic capture (CellSearch, Veridex) and by filtration (ISET, RareCell Diagnostics). CTCs isolated by filtration were assessed by immunohistochemistry for epithelial marker expression (cytokeratins, Epithelial Cell Adhesion Molecule, epidermal growth factor receptor) and for proliferation status (Ki67).
CTCs were detected using ISET in 32 of 40 (80%) patients compared with 9 of 40 (23%) patients using CellSearch. A subpopulation of CTCs isolated by ISET did not express epithelial markers. Circulating tumor microemboli (CTM, clusters of ≥ 3 CTCs) were observed in 43% patients using ISET but were undetectable by CellSearch. Up to 62% of single CTCs were positive for the proliferation marker Ki67, whereas cells within CTM were nonproliferative.
Both technology platforms detected NSCLC CTCs. ISET detected higher numbers of CTCs including epithelial marker negative tumor cells. ISET also isolated CTM and permitted molecular characterization. Combined with our previous CellSearch data confirming CTC number as an independent prognostic biomarker for NSCLC, we propose that this complementary dual technology approach to CTC analysis allows more complete exploration of CTCs in patients with NSCLC.
- > 《医学拾萃》2020年8月刊：样本保存液应用现状与发展前景
- > 《医学拾萃》2020年6月刊：分离胶促凝管对药物浓度监测（TDM）的影响
- > 《医学拾萃》2020年4月刊：凝血途径及不同促凝剂对检测的影响
- > 《医学拾萃》2020年1月刊：EDTA 及 EDTA 盐的合成工艺与其在临床方面的应用
- > 《医学拾萃》2019年12月刊：真空采血管对凝血试验的影响
- > 《医学拾萃》2019年11月刊：静脉血和末梢血在临床检测项目中的差别应用（续）
- > 《医学拾萃》2019年10月刊：静脉血和末梢血在临床检测项目中的差别应用
- > 《医学拾萃》2019年9月刊：肾素-血管紧张素-醛固酮系统（RAAS）及其在相关疾病中的调节作用
- > 《医学拾萃》2019年8月刊：样本收集和液体活检对胰腺癌早期诊断的意义
- > 《医学拾萃》2019年7月刊：全血 RNA 管的应用以及基因表达谱